Ticker

No recent analyst price targets found for YI.

Latest News for YI

111, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Continuing Transition to an Asset-Light Business Model to Improve Overall Efficiency Delivered Non-GAAP Operating Profitability in Both Q4'25 and FY'25 Generated Positive Operating Cash Flow for Both Q4'25 and FY'25 Continued Gross Profit Margin Expansion for B2B Business in Both Q4'25 and FY'25 SHANGHAI, April 9, 2026 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare…

PRNewsWire • Apr 9, 2026
Reviewing 111 (NASDAQ:YI) & Hims & Hers Health (NYSE:HIMS)

Hims and Hers Health (NYSE: HIMS - Get Free Report) and 111 (NASDAQ: YI - Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, risk, valuation, profitability and institutional ownership. Volatility and Risk Hims and Hers Health

Defense World • Feb 5, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for YI.

No House trades found for YI.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top